Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004-2006

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 120, Issue 9-10, 2007, Pages 412-422

  Werckenthin, Christiane ^a   Alešík, Eva ^a   Grobbel, Mirjam ^b   Lübke Becker, Antina ^b   Schwarz, Stefan ^c   Wieler, Lothar H ^b   Wallmann, Jürgen ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c INSTITUT FÜR TIERZUCHT   (Germany)

^d Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit BVL   (Germany)

Author keywords

Antimicrobial agents; In vitro susceptibility testing; Minimum inhibitory concentration; National monitoring program; Veterinary pathogen

Indexed keywords

ANTIINFECTIVE AGENT;

ACTINOMYCETACEAE; ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CATTLE; CATTLE DISEASE; DRUG EFFECT; GERMANY; GOVERNMENT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; SWINE; SWINE DISEASE;

ACTINOMYCETACEAE; ACTINOMYCETALES INFECTIONS; ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; CATTLE DISEASES; DRUG RESISTANCE, MICROBIAL; GERMANY; GOVERNMENT PROGRAMS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SWINE; SWINE DISEASES;

ARCANOBACTERIUM PYOGENES; BOS; BOVINAE; CANIS FAMILIARIS; PSEUDOMONAS AERUGINOSA; SUIDAE; SUS;

EID: 34548624712     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: 10.2376/0005-9366-120-412     Document Type: Article

References (27)

1. Alešík, E. (2006): Antimicrobial susceptibility of Arcanobacterium pyogenes: Evaluation and application of a broth micro-dilution method for susceptibility testing and genotypic characterization of tetracycline resistant strains [in German with English Summary]. Thesis, Ludwig-Maximilians-Universität, München, 201 pp.
2. Anonymous (2000): Leitlinien für den sorgfältigen Umgang mit antimikrobiell wirksamen Tierarzneimitteln. Dtsch. Tierärztebl. 48 (Suppl. 11/02). Schlütersche GmbH & Co KG, Hannover.
3. Aucoin, D. (2005): Target™. The antimicrobial reference guide to effective treatment. 2nd revised edn. Port Huron: North American Compendiums Inc.
4. Billington, S. J., J. G. Songer, B. H. Jost (2002): Widespread distribution of a Tet W determinant among tetracycline-resistant isolates of the animal pathogen Arcanobacterium pyogenes. Antimicrob. Agents Chemother. 46, 1281-1287.
5. Chirino-Trejo, M., M. R. Woodbury, F. Huang (2003): Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis. J. Zoo. Wildl. Med. 34, 262-268.
6. Hariharan, H., M. Coles, D. Pooles, L. Lund, R. Page (2006): Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa. Can. Vet. J. 47, 253-255.
7. Hancock, R. E. W., D. P. Speert (2000): Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Res. Updates 3, 247-255.
8. Jost, B. H., S. J. Billington (2005): Arcanobacterium pyogenes: molecular pathogenesis of an animal opportunist. Antonie van Leeuwenhoek 88, 87-102.
9. Jost, B. H., A. C. Field, H. T. Trinh, J. G. Songer, S. J. Billington (2003): Tylosin resistance in Arcanobacterium pyogenes is encoded by an Erm X determinant. Antimicrob. Agents Chemother. 47, 3519-3524.
10. Jost, B. H., H. T. Trinh, J. G. Songer, S. J. Billington (2004a): A second tylosin resistance determinant, Erm B, in Arcanobacterium pyogenes. Antimicrob. Agents Chemother. 48, 721-727.
11. Jost, B. H., H. T. Trinh, J. G. Songer, S. J. Billington (2004b): Ribosomal mutations in Arcanobacterium pyogenes confer a unique spectrum of macrolide resistance. Antimicrob. Agents Chemother. 48, 1021-1023.
12. Kietzmann, M. (1999): Overview of the pharmacokinetic properties of fluoroquinolones in companion animals. Comp. Cont. Educat. Pract. Vet. 21 (Suppl.), 7-11.
13. Kietzmann, M., A. Böttner, H. M. Hafez, C. Kehrenberg, D. Klarmann, P. Krabisch, T. Kühn, G. Luhofer, A. Richter, S. Schwarz, W. Traeder, K.-H. Waldmann, J. Wallmann, C. Werckenthin (2004): Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint [in German with English Abstract]. Berl. Münch. Tierärztl. Wochenschr. 117, 81-87.
14. Kroker, R., R. Scherkl, F. R. Ungemach (2002): Chemotherapie bakterieller Infektionen. In: H.-H. Frey, W. Löscher, eds. Lehrbuch der Pharmakologie und Toxikologie für die Veterinärmedizin. Stuttgart: Enke Verlag, 368.
15. Meunier, D., J.-F. Acar, J.-L Martel, S. Kroemer, M. Valle (2004): A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. Int. J. Antimicrob. Agents 24, 592-598.
16. McGowan Jr., J. E. (2006): Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am. J. Med. 119, S29-S36.
17. Narayanan, S., T. G. Nagaraja, J. Staats, M. M. Chengappa, R. D. Oberst (1998): Biochemical and biological characterizations and ribotyping of Actinomyces pyogenes and Actinomyces pyogenes-like organisms from liver abscesses in cattle. Vet. Microbiol. 61, 289-303.
18. National Committee for Clinical Laboratory Standards (2002): Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. 2nd edn. NCCLS document M-31-A2. National Committee for Clinical Laboratory Standards, Wayne, PA, U.S.A.
19. National Committee for Clinical Laboratory Standards (2004): Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard; Informational supplement (May 2004). NCCLS document M31-S1. National Committee for Clinical Laboratory Standards, Wayne, PA, U.S.A.
20. Quinn, P. J., M. E. Carter, B. K. Markey, G. R. Carter (1994): Clinical Veterinary Microbiology. London: Mosby.
21. Schick, A. E., J. C. Angus, K. S. Coyner (2007): Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa. Vet. Dermatol. 18, 120-126.
22. Schröder, A., M. Hoedemaker, G. Klein (2005): Resistenzen von Mastitiserregern im norddeutschen Raum [in German with English Abstract]. Berl. Münch. Tierärztl. Wochenschr. 118, 393-398.
23. Schwarz, S., E. Alešík, M. Grobbel, A. Lübke-Becker, J. Wallmann, C. Werckenthin, L. H. Wieler (2007): The BfT-GermVet monitoring program - aims and basics. Berl. Münch. Tierärztl. Wochenschr. 120, 357-362.
24. Šeol, B., T. Naglić, J. Madić, M. Bedeković (2002): In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents. J. Vet. Med. B 49, 188-192.
25. Sheldon, I. M., M. Bushnell, J. Montgomery, A. N. Rycroft (2004): Minimum inhibitory concentrations of some antimicrobial drugs against bacteria causing uterine infections in cattle. Vet. Rec. 155, 383-387.
26. Trinh, H. T., S. J. Billington, A. C. Field, J. G. Songer, B. H. Jost (2002): Susceptibility of Arcanobacterium pyogenes from different sources to tetracycline, macrolide and lincosamide antimicrobial agents. Vet. Microbiol. 85, 353-359.
27. Veyssier, P., A. Bryskier (2005): Dihydrofolate reductase inhibitors, nitroheterocycles (furans), and 8-hydroxyquinolines. In: Bryskier, A., ed. Antimicrobial Agents - Antibacterials and Antifungals. Washington, DC: ASM Press, 941-963.